Regor Therapeutics Announces Completion of $90 Million Series B Financing
News provided by
Share this article
Share this article
SHANGHAI, Feb. 18, 2021 /PRNewswire/ Regor Therapeutics, a clinical stage biotechnology company dedicated to the discovery of innovative medicines to treat cancer, immune disorders and metabolic diseases, announces the successful completion of $90 million Series B financing.
Founded in July of 2018 by a group of veteran drug hunters with extensive research and executive leadership experiences at top multinational pharmaceutical companies, Regor aims to establish world-class innovation capabilities and is committed to delivering clinically differentiated, best- and first-in-class drugs to serve patients globally. By leveraging CARD, Computer Accelerated Rational Discovery, a proprietary enabling technology platform, the team has successfully advanced numerous discovery programs in a dramatically accelerated fashion, including from ideas to a clinica
Regor Therapeutics Announces Completion of $90 Million Series B Financing
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Los Angeles County Employees allocates $390 million to 5 funds
Print
Los Angeles County Employees Retirement Association, Pasadena, Calif., committed a total of $390 million to five alternative investment funds, according to an executive session report on the $65.4 billion pension fund s website.
LACERA s board of investment at its Jan. 13 meeting approved commitments of up to $100 million total to venture capital funds LAV Fund VI and LAV Fund VI Opportunities, both managed by
Lilly Asia Ventures.
The board also approved commitments of up to $100 million each to Grain Communications Opportunity Fund III, a telecommunications infrastructure fund managed by
Grain Management; and buyout fund
Novacap TMT VI; and up to €75 million ($90 million) to
February 14, 2021
Southeast Asia has drawn increasing interest from global venture capital (VC) firms wanting a slice of the emerging market growth story. A total of $4.08 billion was raised by nine global funds in 2020 with significant allocations for private companies in the region, a massive jump from $867 million bagged by five funds in 2019, per our latest report, SE Asia’s VC Funds: Q4 2020 Review.
On the other hand, Southeast Asia’s venture capital firms suffered a significant 39% drop in fundraising at $1.96 billion in 2020, as travel restrictions in the wake of the COVID-19 pandemic and increased limited partner caution affected fundraising.
Staying with data-led stories, we captured deal-making activity in Greater China where private equity and venture capital firms took a breather in January after the hectic deal flow witnessed towards the end of 2020. Chinese startups collected almost $7.5 billion in January 2021, down 17.6% from December, according to our data. Th
San Francisco Employees allocates $148 million to 3 alts funds
Print
San Francisco City & County Employees Retirement System disclosed commitments and investments totaling $148 million in a report from CIO William J. Coaker Jr. ahead of its Feb. 10 board meeting.
The $30.7 billion pension fund made a direct hedge fund investment of $100 million in
RTW Innovation Fund, an opportunistic fund that invests in health-care companies managed by RTW Investments.
It is SFERS first investment with RTW and is classified as an opportunistic investment within the pension fund s public equities portfolio.
As of Jan. 31, the actual allocation to public equities was 39.4%.
Also, SFERS committed $32 million to multistage venture capital fund LAV Fund VI and $16 million to late-stage venture capital fund LAV Fund VI Opportunities, both managed by
vimarsana © 2020. All Rights Reserved.